The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-1715-2019·Announced 2019-08-14

RXQ Compounding Recalls Turbo Drops Ophthalmic Solution Due to Sterility Concerns

RXQ Compounding LLC is recalling Turbo Drops ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury or hospitalization reports, or structural defects, are rated as Severe. Lack of sterility assurance in ophthalmic products poses a significant risk of serious injury.

Plain-English summary

RXQ Compounding LLC is recalling Turbo Drops (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) Ophthalmic Solution, 5 mL per dropper bottle. The recall is being conducted because the product lacks assurance of sterility.

The affected product is identified by NDC 70731-0205-05. The recall includes all lots within expiry. The product was distributed nationwide in the United States.

Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
TURBO DROPS (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0205-05

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 86 recalled by RXQ Compounding LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 86 products in this recall →

Similar recalls